During the past decade, Tacoma Center For Arthritis Research Ps conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 10 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tacoma Center For Arthritis Research Ps" #1 sponsor was "Pfizer" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tacoma Center For Arthritis Research Ps" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Tacoma Center For Arthritis Research Ps" are "Rheumatoid Arthritis" (3 trials), "Arthritis, Rheumatoid" (2 trials), "Osteoarthritis" (2 trials), "Arthritis" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Tacoma Center For Arthritis Research Ps" in a lesser frequency.

Most popular intervention types in "Tacoma Center For Arthritis Research Ps" are "Drug" (14 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Methotrexate" (2 trials), "Apremilast 20mg" (1 trials), "Apremilast 30mg" (1 trials) and "BI 695500" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tacoma Center For Arthritis Research Ps" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Tacoma Center For Arthritis Research Ps". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Tacoma Center For Arthritis Research Ps, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Tacoma Center For Arthritis Research Ps, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".